Fineheart Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
88
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$56.3M
- Investors
-
20
Fineheart General Information
Description
Developer of implantable cardiac devices designed to treat cardiovascular diseases. The company's device is a novel, wirelessly powered, fully implantable mechanical circulatory support device that can optimize cardiac output while preserving the heart's innate contractility, enabling patients to restore normal cardiac output and allow heart failure patients to return to a normal quality of life.
Contact Information
Website
www.fineheart.frCorporate Office
- 28 Avenue Gustave Eiffel
- Bâtiment C
- 33600 Pessac
- France
Corporate Office
- 28 Avenue Gustave Eiffel
- Bâtiment C
- 33600 Pessac
- France
Fineheart Timeline
Fineheart Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Grant | 09-Jan-2026 | $56.3M | Completed | Generating Revenue | ||
| 13. Later Stage VC (Series C) | 23-Dec-2025 | Completed | Generating Revenue | |||
| 12. Grant | 13-Mar-2024 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 28-Nov-2023 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series C) | Cancelled | Pre-Clinical Trials | ||||
| 9. Grant | 08-Dec-2022 | Completed | Pre-Clinical Trials | |||
| 8. Grant | 15-Jun-2022 | Completed | Pre-Clinical Trials | |||
| 7. Later Stage VC (Series B) | 15-Dec-2021 | Completed | Pre-Clinical Trials | |||
| 6. Later Stage VC | 01-Jan-2018 | $59.2M | Cancelled | Pre-Clinical Trials | ||
| 5. Accelerator/Incubator | $7M | Completed | Pre-Clinical Trials |
Fineheart Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Fineheart Patents
Fineheart Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026180778-A1 | Assembly for assisting with the fitting of a heart pump | Pending | 28-Feb-2025 | ||
| FR-3172614-A1 | Heart pump implantation assistance kit | Pending | 28-Feb-2025 | ||
| FR-3172615-A1 | Heart pump implantation assistance kit | Pending | 28-Feb-2025 | ||
| EP-4799674-A1 | Implantable assembly comprising an implantable medical lead and a stiffening member for stiffening a part of this medical lead | Pending | 28-Feb-2025 | ||
| US-20260335629-A1 | Implantable assembly comprising an implantable medical lead and a stiffening member for stiffening a part of this medical lead | Pending | 28-Feb-2025 | A61M60/878 |
Fineheart Signals
Fineheart Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| IPCEI | Corporation | |||
| ETCHART Group | Holding Company | Minority | ||
| Groupe Pasteur Mutualité | Corporation | Minority | ||
| Lurra Capital | Other Private Equity | Minority | ||
| European Regional Development Fund (Brandenburg) | Government |
Fineheart FAQs
-
When was Fineheart founded?
Fineheart was founded in 2010.
-
Where is Fineheart headquartered?
Fineheart is headquartered in Pessac, France.
-
What is the size of Fineheart?
Fineheart has 88 total employees.
-
What industry is Fineheart in?
Fineheart’s primary industry is Therapeutic Devices.
-
Is Fineheart a private or public company?
Fineheart is a Private company.
-
What is Fineheart’s current revenue?
The current revenue for Fineheart is .
-
How much funding has Fineheart raised over time?
Fineheart has raised $75.6M.
-
Who are Fineheart’s investors?
IPCEI, ETCHART Group, Groupe Pasteur Mutualité, Lurra Capital, and European Regional Development Fund (Brandenburg) are 5 of 20 investors who have invested in Fineheart.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process